financetom
Business
financetom
/
Business
/
OppFi Q2 Adjusted Earnings, Revenue Rise; Raises 2025 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OppFi Q2 Adjusted Earnings, Revenue Rise; Raises 2025 Outlook
Aug 6, 2025 6:34 AM

09:00 AM EDT, 08/06/2025 (MT Newswires) -- OppFi ( OPFI ) reported Q2 adjusted earnings Wednesday of $0.45 per share, up from $0.29 a year earlier.

Three analysts polled by FactSet expected $0.30.

Total revenue for the quarter ended June 30 was $142.4 million, compared with $126.3 million a year earlier.

Four analysts surveyed by FactSet expected $141.2 million.

For 2025, adjusted EPS is now projected to be between $1.39 and $1.44, up from a prior guidance of between $1.18 and $1.26. Four analysts surveyed by FactSet expect $1.24.

Total revenue for the year is expected in the range of $578 million to $605 million, up from a prior guidance of between $563 million to $594 million. Four analysts surveyed by FactSet expect $581.8 million.

Shares of the company were up 16% in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment
Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment
Oct 2, 2024
04:37 PM EDT, 10/02/2024 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Wednesday it is collaborating with AstraZeneca ( AZN ) in a clinical trial to evaluate a combination of casdatifan with volrustomig to treat patients with clear cell renal cell carcinoma. Casdatifan is Arcus's investigational and volrustomig is AstraZeneca's ( AZN ) investigational PD-1/CTLA-4 bispecific antibody. This is...
Simulations Plus Insider Sold Shares Worth $625,200, According to a Recent SEC Filing
Simulations Plus Insider Sold Shares Worth $625,200, According to a Recent SEC Filing
Oct 2, 2024
04:39 PM EDT, 10/02/2024 (MT Newswires) -- Walter S Woltosz, 10% Owner, Director, on October 01, 2024, sold 20,000 shares in Simulations Plus ( SLP ) for $625,200. Following the Form 4 filing with the SEC, Woltosz has control over a total of 3,481,592 shares of the company, with 3,481,592 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1023459/000102345924000115/xslF345X05/wk-form4_1727901252.xml ...
Radiant Logistics Acquires Focus Logistics
Radiant Logistics Acquires Focus Logistics
Oct 2, 2024
04:38 PM EDT, 10/02/2024 (MT Newswires) -- Radiant Logistics ( RLGT ) said late Wednesday it has acquired Focus Logistics, which has operated under the company's Service By Air brand since 2006 and is now expected to transition to the Radiant brand. The purchase price is payable in subsequent periods based on the future performance of Focus Logistics, Radiant said....
OpenAI tells investor to not invest in five AI startups including Sutskever's SSI
OpenAI tells investor to not invest in five AI startups including Sutskever's SSI
Oct 2, 2024
(Reuters) - As global investors such as Thrive Capital and Tiger Global invest $6.6 billion in OpenAI, the ChatGPT-maker sought a commitment beyond just capital - they also wanted investors to refrain from funding five companies they perceive as close competitors, sources told Reuters. The list of companies includes rivals developing large language models such as Anthropic and Elon Musk's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved